Clinical trial
Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia
NCT00249132 is registered in ClinicalTrials.gov with Janssen, LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia
- Lead sponsor
- Janssen, LP
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- July 31, 1991
- Enrollment
- 523 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.